Relief Therapeutics Holding AG (RLFTF)

[aGuyUS]

PEnny PHasbio (PHAS) has a VIP Derivative Peptide it is in clinical trial for treating SARS which increases the bioavailability of VIP in the Blood stream how they do it is to by attaching something I forget off hand to the 28 String Amino ACid's that make up the base VIP structure and that inhibits the VIP structure from breaking down..

It is in some form of CLinical Trial as we speak Think it went into Phase 2 a month or so ago and should be pretty quickly coming out. They are going after MOderate Severe COVID19 patients.

I haven't looked into it in over a montha nd I really should get back to it as I believe all VIP research now is going to Gobbled up

https://clinicaltrials.gov/ct2/show/NCT04433546?

Drug: Pemziviptadil (PB1046)